PharVision Advisers’s Grindr GRND Stock Holding History

PharVision Advisers’s Portfolio GRND Stock Details GRND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,609	Closed	-$309K	–	714
2025 Q2	$309K	Buy	+13,609	New	+$299K	0.44%	75
2025 Q1	–	Sell	-13,903	Closed	-$248K	–	372
2024 Q4	$248K	Buy	+13,903	New	+$203K	0.21%	225

Other funds holding GRND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

PharVision Advisers's GRND Position: Q3 2025 in Review

PharVision Advisers sold out of Grindr (GRND) in Q3 2025, closing a stake of 13,609 shares — an estimated $309K sold.

PharVision Advisers first reported a position in GRND in Q4 2024 and held it in 2 quarters. The position peaked at $309K in Q2 2025. 164 funds tracked by Wall St. Rank hold GRND as of Q3 2025.

PharVision Advisers reported no remaining Grindr position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 13,609 Grindr shares in Q3 2025, an estimated $309K.
PharVision Advisers first reported a position in Grindr in Q4 2024 and held it in 2 quarters.
PharVision Advisers's Grindr position peaked at $309K in Q2 2025.
164 funds tracked by Wall St. Rank held Grindr as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.